Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zaoren Ningxin dripping pills (formerly known as Anshen dripping pills) is a Class 1.1 innovative traditional Chinese medicine developed by Tasly. It is formulated as a dripping pill containing four herbal ingredients: fried Ziziphi Spinosae Semen (炒酸枣仁), Albiziae Flos (合欢花), Notoginseng Folium (三七叶), and Glycyrrhizae Radix et Rhizoma (甘草). The formulation is derived from a clinical experience prescription of Academician Boli Zhang. It is indicated for the treatment of insomnia, specifically sleep initiation and maintenance disorders (characterized by frequent awakenings) associated with heart-liver blood deficiency syndrome in traditional Chinese medicine. Zaoren Ningxin dripping pills received marketing approval from China's National Medical Products Administration (NMPA) on June 5, 2026.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zaoren Ningxin dripping pills.